Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Sanidad Militar
versión impresa ISSN 1887-8571
Resumen
PEREZ MORAN, MªJ; CABANES MARISCAL, MªÁ; APARICIO HERNANDEZ, R y GARCIA LUQUE, A. Positive assessment of drugs: May, June and July 2018. Sanid. Mil. [online]. 2018, vol.74, n.4, pp.236-247. ISSN 1887-8571. https://dx.doi.org/10.4321/s1887-85712018000400005.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in May, June and July of 2018, and considered of interest to the healthcare professional, are reviewed here. These are positive technical reports prior to the authorization and placing on the market of the product.
Palabras clave : Abemaciclib (Verzenios®); Adalumumab (Halimatoz®, Hefiya®, Hyrimoz®, Hulio®); Binimetinib (Mektovi®); Caplacizumab (Cablivi®); Durvalumab (Imfinzi®); Encorafenib (Braftovi®); Erenumab (Aimovig®); Eravaciclina (Xevara®); Inotersen (Tegsedi®); Lesinurad/alopurinol (Duzallo®); Melatonina(slenyto®); Metreleptina (Myaleota®); Neratinib (Nerlynx®); Patisiran (Onpattro®); Pegfilgrastim (Pelgraz®); Pegfilgrastim (Udenyca®); Tezacaftor/ivacaftor (Symkevi®); Tildrakizumab (Ilumetri®); Tisagenlecleucel (Kymriah®); Trastuzumab (Trazimera®); Vestronidasa alfa (Mepsevii®); Vigabatrina (Kigabeq®); Vonicog alfa (Veyvondi®); Daunorubicina/citarabina (Vyxeos); Axicabtagen ciloleucel (Yescarta®).